HomeCompareGORV vs ABBV

GORV vs ABBV: Dividend Comparison 2026

GORV yields 475.06% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GORV wins by $181.8K in total portfolio value
10 years
GORV
GORV
● Live price
475.06%
Share price
$0.42
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$284.1K
Annual income
$668.52
Full GORV calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — GORV vs ABBV

📍 GORV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGORVABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GORV + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GORV pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GORV
Annual income on $10K today (after 15% tax)
$40,380.05/yr
After 10yr DRIP, annual income (after tax)
$568.24/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, ABBV beats the other by $20,487.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GORV + ABBV for your $10,000?

GORV: 50%ABBV: 50%
100% ABBV50/50100% GORV
Portfolio after 10yr
$193.2K
Annual income
$12,720.14/yr
Blended yield
6.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

GORV
No analyst data
Altman Z
-1.3
Piotroski
3/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GORV buys
0
ABBV buys
0
No recent congressional trades found for GORV or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGORVABBV
Forward yield475.06%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%40.6%
Portfolio after 10y$284.1K$102.3K
Annual income after 10y$668.52$24,771.77
Total dividends collected$167.2K$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GORV vs ABBV ($10,000, DRIP)

YearGORV PortfolioGORV Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$34,453$23,752.97$11,550$430.00+$22.9KGORV
2$75,106$38,241.14$13,472$627.96+$61.6KGORV
3$119,318$38,955.06$15,906$926.08+$103.4KGORV
4$156,590$28,919.02$19,071$1,382.55+$137.5KGORV
5$185,286$17,734.77$23,302$2,095.81+$162.0KGORV
6$208,062$9,805.97$29,150$3,237.93+$178.9KGORV
7$227,771$5,145.50$37,536$5,121.41+$190.2KGORV
8$246,348$2,632.21$50,079$8,338.38+$196.3KGORV
9$264,922$1,330.32$69,753$14,065.80+$195.2KGORV
10$284,135$668.52$102,337$24,771.77+$181.8KGORV

GORV vs ABBV: Complete Analysis 2026

GORVStock

Lazydays Holdings, Inc. operates recreational vehicle (RV) dealerships under the Lazydays name in the United States. The company offers RV sales, RV-repair and services, financing and insurance products, third-party protection plans, and after-market parts and accessories. It also operates the Lazydays RV resort at Tampa, Florida. The company was founded in 1976 and is based in Tampa, Florida.

Full GORV Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this GORV vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GORV vs SCHDGORV vs JEPIGORV vs OGORV vs KOGORV vs MAINGORV vs JNJGORV vs MRKGORV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.